Methods | Parallel randomised controlled trial |
Participants | SETTING: Inpatients and outpatients at Liyuan Hospital, China |
WHO PARTCIPATED: 62 people (32 in intervention group, M/F 17/15, mean age 65.3 yrs, mean disease duration 3.1yrs, mean weight 82.3kg; 30 in control group, M/F 15/15, mean age 66.1 yrs, mean disease duration 3.6yrs, mean weight 82.1kg) | |
INCLUSION CRITERIA: IGT according to WHO,1998 | |
EXCLUSION CRITERIA: none reported | |
CO-MORBIDITIES: none reported | |
CO-MEDICATIONS: none reported | |
Interventions | INTERVENTION: Fufang cangzhu decoction (cang zhu 15g, yi yi ren 24g, sang shen 20g, shan yao 30g, huang bai 10g, li zhi hue 20g, di long 10g) oral, decoction, 150ml, bid |
CONTROL: metformin 0.25g, oral, tablet, tid | |
Outcomes | FBG (mmol/L), 1hr-GTT (mmol/L), 2hr-GTT (mmol/L), weight (kg), waist-hip ratio (WHR), triglycerides (mmol/L), total cholesterol (mmol/L), fasting insulin (mU/L) |
All outcomes measured at baseline and at trial completion (8 weeks). | |
Study details | DURATION OF INTERVENTION: 8 weeks |
DURATION OF FOLLOW-UP: 8 weeks | |
RUN-IN PERIOD: none | |
Publication details | LANGUAGE OF PUBLICATION: Chinese |
COMMERCIAL FUNDING: no | |
NON-COMMERCIAL FUNDING: no | |
PUBLICATION STATUS (PEER REVIEW JOURNAL): yes | |
PUBLICATION STATUS (JOURNAL SUPPLEMENT): no | |
PUBLICATION STATUS (ABSTRACT): yes | |
Stated aim of study | Quote “To observe therapeutic effect of Fufang Cangzhu Decoction on senile obesity or overweight with impaired glucose tolerance (IGT)”. |
Notes |
Risk of bias table